Latest Fy27 Outlook News

Netwealth has broadened its partnership with Morgan Stanley Wealth Management Australia by providing a new domestic platform for ASX equities and investments, underpinning robust FY26 fund inflows and an optimistic FY27 outlook.

Promisia Healthcare’s aged care occupancy climbed to a record 96% in June 2026, underpinning its FY27 earnings growth guidance. Aldwins House led the turnaround, while solar initiatives and wellness programs roll out across sites.

The a2 Milk Company faced significant supply chain disruptions in its China infant formula segment during late FY26, causing a 14% sales decline in that category. Despite this, overall revenue rose 12% on FY25, supported by strong performances in other product lines and improved margins.

Comms Group Limited is set to divest its onPlatinum division for $30 million, aiming to strengthen its balance sheet and return capital to shareholders. The company maintains solid FY26 guidance, driven by organic growth and cost rationalisation.

Burger Fuel Group posted a 92% surge in net profit to NZ$1.97 million for FY26, driven by steady system sales growth, a one-off store sale gain, and reduced legal expenses, while geopolitical instability in the Middle East weighs on international sales.

Autosports Group reports a 22% jump in order write driven by battery electric vehicles, with FY26 profit forecast raised to $51-54 million.

Golding Contractors, a subsidiary of NRW Holdings, has secured two major contracts worth up to $195 million, underpinning its regional presence and boosting NRW's FY27 order book.

SunRice reported a 4% rise in net profit after tax for FY26 to $73.3 million, maintaining an 8% EBITDA margin despite a 2.5% revenue decline. The company declared a record fully franked dividend of 70 cents per share but expects FY27 profit to fall amid a smaller Australian rice crop.

Tasmea Limited forecasts over 70% earnings growth in FY27, driven by acquisitions and organic expansion, underpinned by a record order book and strong industry demand.

Matrix Composites & Engineering has landed a significant A$34 million subsea buoyancy contract, boosting its FY27 workload as it navigates a major acquisition proposal.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

Emeco Holdings expects FY26 operating EBITDA near $290 million despite weather and supply headwinds, while FY27 outlook targets stable earnings with improved utilisation and ongoing deleveraging.